{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:54:59Z","timestamp":1791194099575,"version":"4.1.0"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Eosinophilic granulomatosis with polyangiitis (EGPA) is a multisystem immune-mediated disease characterized by adult-onset asthma, eosinophilic inflammation, and necrotizing vasculitis of small-to-medium-sized vessels. Diagnosis is frequently prompted by clinically overt neurological, cardiac, renal, cutaneous, or gastrointestinal involvement. However, potentially informative manifestations may already be recognizable earlier, particularly when asthma, chronic rhinosinusitis with nasal polyps, and blood eosinophilia coexist with otherwise nonspecific extrapulmonary findings. Most cohorts describe manifestations at diagnosis or during established disease and provide limited information on their early temporal appearance across different specialties. This gap is particularly relevant to arthralgia and myalgia, which are common but poorly characterized, and to eosinophilic gastrointestinal manifestations that may initially be classified as organ-restricted eosinophilic gastrointestinal disorders. Biopsy-proven myositis is rare but has occasionally been reported at presentation or before clinically recognizable neuropathy. This review examines early and potentially recognizable manifestations of EGPA across outpatient settings, with particular attention to musculoskeletal symptoms, objective muscle involvement, eosinophilic gastrointestinal disease, and the therapeutic implications of distinguishing organ-restricted eosinophilic disease from systemic EGPA.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1964154","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:30:46Z","timestamp":1791192646000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Early recognition of eosinophilic granulomatosis with polyangiitis in outpatient settings: musculoskeletal and gastrointestinal clues beyond respiratory disease"],"prefix":"10.3389","volume":"17","author":[{"given":"Ernesto","family":"Aitella","sequence":"first","affiliation":[{"name":"Department of Life, Health and Environmental Sciences, University of L\u2019Aquila","place":["L\u2019Aquila, Italy"]},{"name":"Allergy and Clinical Immunology Unit, Center for the Diagnosis and Treatment of Osteoporosis","place":["Teramo, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"De Martinis","sequence":"additional","affiliation":[{"name":"Department of Life, Health and Environmental Sciences, University of L\u2019Aquila","place":["L\u2019Aquila, Italy"]},{"name":"Long-Term Care Unit, \u201cMaria SS. dello Splendore\u201d Hospital","place":["Giulianova, Italy"]},{"name":"UniCamillus-Saint Camillus International University of Health Sciences","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lia","family":"Ginaldi","sequence":"additional","affiliation":[{"name":"Department of Life, Health and Environmental Sciences, University of L\u2019Aquila","place":["L\u2019Aquila, Italy"]},{"name":"Allergy and Clinical Immunology Unit, Center for the Diagnosis and Treatment of Osteoporosis","place":["Teramo, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.627776","article-title":"Eosinophilic granulomatosis with polyangiitis: dissecting the pathophysiology","volume":"8","author":"Fagni","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez570","article-title":"Eosinophilic granulomatosis with polyangiitis: understanding the disease and its management","volume":"59","author":"Trivioli","year":"2020","journal-title":"Rheumatology"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.885198","article-title":"Clinical significance of MPO-ANCA in eosinophilic granulomatosis with polyangiitis: experience from a longitudinal Chinese cohort","volume":"13","author":"Liu","year":"2022","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1080\/1744666X.2019.1697678","article-title":"Eosinophilic granulomatosis with polyangiitis: the multifaceted spectrum of clinical manifestations at different stages of the disease","volume":"16","author":"Berti","year":"2020","journal-title":"Expert Rev Clin Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/art.37721","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg\u2010Strauss): clinical characteristics and long\u2010term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort","volume":"65","author":"Comarmond","year":"2013","journal-title":"Arthritis Rheum"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00097-2016","article-title":"Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg\u2013Strauss)","volume":"48","author":"Cottin","year":"2016","journal-title":"Eur Respir J"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12226967","article-title":"Early ear, nose and throat manifestations in eosinophilic granulomatosis with poliangioitis: results from our cohort group and literature review","volume":"12","author":"D\u2019Onofrio","year":"2023","journal-title":"J Clin Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ejim.2024.06.008","article-title":"Red flags for clinical suspicion of eosinophilic granulomatosis with polyangiitis (EGPA)","volume":"128","author":"Solans-Laqu\u00e9","year":"2024","journal-title":"Eur J Intern Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2024-BTSabstracts.396","article-title":"P235\u2005The diagnostic journey of patients with eosinophilic granulomatosis with polyangiitis (EGPA) in England: a retrospective observational cohort study","volume":"79","author":"Siddiqui","year":"2024","journal-title":"\u2018The Number One Asthma Detective Agency\u2019 \u2013 Asthma diagnostics"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu427","article-title":"Value of commonly measured laboratory tests as biomarkers of disease activity and predictors of relapse in eosinophilic granulomatosis with polyangiitis","volume":"54","author":"Grayson","year":"2015","journal-title":"Rheumatology"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-020-08788-4","article-title":"Cutaneous vasculitis: review on diagnosis and clinicopathologic correlations","volume":"61","author":"Frumholtz","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.18926\/AMO\/54501","article-title":"A diagnostic algorithm for eosinophilic granulomatosis with polyangiitis initially diagnosed as lumbar disc hernia or lumbar spinal stenosis: personal experience and review of the literature","volume":"70","author":"Nagata","year":"2016","journal-title":"Acta Med Okayama"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2019.01.013","article-title":"Peripheral nerve vasculitis","volume":"37","author":"Gwathmey","year":"2019","journal-title":"Neurol Clin"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa416","article-title":"Renal involvement in eosinophilic granulomatosis with polyangiitis (EGPA): a multicentric retrospective study of 63 biopsy-proven cases","volume":"60","author":"Durel","year":"2021","journal-title":"Rheumatology"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2025-005816","article-title":"Coronary vasospasms and other cardiac manifestations in eosinophilic granulomatosis with polyangiitis: clinical impact and frequency in a monocentre study of 103 patients","volume":"11","author":"Schramm","year":"2025","journal-title":"RMD Open"},{"key":"B17","doi-asserted-by":"publisher","first-page":"A2229","DOI":"10.1016\/j.chest.2022.08.1844","article-title":"Cardiac manifestations of eosinophilic granulomatosis with polyangiitis","volume":"162","author":"Keogh","year":"2022","journal-title":"Chest"},{"key":"B18","doi-asserted-by":"publisher","first-page":"AB109","DOI":"10.1016\/j.jaci.2022.12.347","article-title":"Patient profiles in eosinophilic granulomatosis with polyangiitis (EGPA) - insights from allergy practice","volume":"151","author":"Wechsler","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2018.07.001","article-title":"Eosinophilic granulomatosis with polyangiitis: clinical pathology conference and review","volume":"6","author":"Wu","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B20","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.jaip.2024.10.013","article-title":"Characteristics of severe asthma clinic patients with eosinophilic granulomatosis with polyangiitis","volume":"13","author":"Puan","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jaci.2010.04.011","article-title":"Practical approach to the patient with hypereosinophilia","volume":"126","author":"Roufosse","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-020-04567-8","article-title":"Eosinophilic granulomatosis with polyangiitis presenting with myositis: case based review","volume":"40","author":"Koppikar","year":"2020","journal-title":"Rheumatol Int"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1259\/bjr\/14063641","article-title":"Skeletal muscle disease: patterns of MRI appearances","volume":"85","author":"Theodorou","year":"2012","journal-title":"Br J Radiol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2016.12.002","article-title":"The yield of diagnostic work-up of patients presenting with myalgia, exercise intolerance, or fatigue","volume":"27","author":"te Riele","year":"2017","journal-title":"Neuromuscular Disord"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e210141","DOI":"10.1212\/WNL.0000000000210141","article-title":"Vasculitic myopathy","volume":"103","author":"Pinto","year":"2024","journal-title":"Neurology"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-15-388","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) presenting as diffuse myositis","volume":"15","author":"Parent","year":"2014","journal-title":"BMC Musculoskelet Disord"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5728(03)00255-8","article-title":"Muscle inflammation and MHC class I up-regulation in muscular dystrophy with lack of dysferlin: an immunopathological study","volume":"142","author":"Confalonieri","year":"2003","journal-title":"J Neuroimmunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.nmd.2024.01.003","article-title":"An up-to-date myopathologic characterisation of facioscapulohumeral muscular dystrophy type 1 muscle biopsies shows sarcolemmal complement membrane attack complex deposits and increased skeletal muscle regeneration","volume":"36","author":"Hubregtse","year":"2024","journal-title":"Neuromuscular Disord"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3988\/jcn.2020.16.4.717","article-title":"A case of myositis preceding neuropathy in eosinophilic granulomatosis with polyangiitis","volume":"16","author":"Woo","year":"2020","journal-title":"J Clin Neurol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"rxaf032","DOI":"10.1093\/mrcr\/rxaf032","article-title":"Anti-neutrophil cytoplasm antibody-negative eosinophilic granulomatous polyangiitis complicated by myositis: a case report","volume":"9","author":"Nakagawa","year":"2025","journal-title":"Mod Rheumatol Case Rep"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-024-03467-7","article-title":"Gastrointestinal lesions of eosinophilic granulomatosis with polyangiitis: a prediction model and clinical patterns","volume":"27","author":"Liu","year":"2025","journal-title":"Arthritis Res Ther"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1099722","article-title":"Clinical characteristics and long-term outcome of patients with gastrointestinal involvement in eosinophilic granulomatosis with polyangiitis","volume":"13","author":"Li","year":"2023","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1186\/2193-1801-3-404","article-title":"Gastrointestinal perforation due to vasculitis at primary diagnosis of eosinophilic granulomatosis with polyangiitis (EGPA) despite a high dose glucocorticosteroids treatment","volume":"3","author":"Assmann","year":"2014","journal-title":"Springerplus"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.4103\/ecdt.ecdt_61_25","article-title":"Gastrointestinal involvement as the initial presentation of eosinophilic granulomatosis with polyangiitis: a rare case report","volume":"75","author":"Akl","year":"2026","journal-title":"Egypt J Chest Dis Tuberc"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2017.00261","article-title":"Eosinophilic gastrointestinal disorders pathology","volume":"4","author":"Collins","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1136\/gut.31.1.54","article-title":"Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues","volume":"31","author":"Talley","year":"1990","journal-title":"Gut"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.3391-19","article-title":"Eosinophilic granulomatosis with polyangiitis initially diagnosed as eosinophilic gastroenteritis","volume":"59","author":"Itawaki","year":"2020","journal-title":"Internal Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1159\/000369129","article-title":"Eosinophilic granulomatosis with polyangiitis and diffuse gastrointestinal involvement","volume":"8","author":"Franco","year":"2014","journal-title":"Case Rep Gastroenterol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.815842","article-title":"Type 2 inflammation in eosinophilic esophagitis: from pathophysiology to therapeutic targets","volume":"12","author":"Racca","year":"2022","journal-title":"Front Physiol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.7523-26","article-title":"Eosinophils in the immunologic spectrum of eosinophilic granulomatosis with polyangiitis: from fundamental pathobiology to emerging therapeutic strategies and future perspectives","author":"Hasegawa","year":"2026","journal-title":"Internal Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3390\/ijms27031206","article-title":"Immunosenescence and allergy: molecular and cellular links between inflammaging, neuro-immune aging, and response to biologic therapies","volume":"27","author":"Aitella","year":"2026","journal-title":"Int J Mol Sci"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1702079","article-title":"Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis","volume":"376","author":"Wechsler","year":"2017","journal-title":"N Engl J Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2311155","article-title":"Benralizumab versus mepolizumab for eosinophilic granulomatosis with polyangiitis","volume":"390","author":"Wechsler","year":"2024","journal-title":"N Engl J Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1186\/s12865-025-00777-6","article-title":"Efficacy and safety of depemokimab in asthma with eosinophilic phenotype: a systematic review and meta-analysis of randomized controlled trials","volume":"27","author":"Gill","year":"2025","journal-title":"BMC Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s12931-026-03801-4","article-title":"Depemokimab: toward biannual biologic therapy for severe eosinophilic asthma","volume":"27","author":"Papavassiliou","year":"2026","journal-title":"Respir Res"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1783889","article-title":"Depemokimab and the twice-yearly regimen: pharmacological implications and therapeutic positioning in severe eosinophilic respiratory diseases","volume":"17","author":"Marra","year":"2026","journal-title":"Front Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1136\/ard-2022-223764","article-title":"EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update","volume":"83","author":"Hellmich","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102737","article-title":"Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis: a systematic literature review","volume":"20","author":"Akiyama","year":"2021","journal-title":"Autoimmun Rev"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-016-3152-1","article-title":"The effect of cyclophosphamide on the immune system: implications for clinical cancer therapy","volume":"78","author":"Ahlmann","year":"2016","journal-title":"Cancer Chemother Pharmacol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.18176\/jiaci.0823","article-title":"Eosinophilia induced by blocking the IL-4\/IL-13 pathway: potential mechanisms and clinical outcomes","volume":"32","author":"Olaguibel","year":"2022","journal-title":"J Investigational Allergy Clin Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s40272-020-00387-2","article-title":"Dupilumab to treat type 2 inflammatory diseases in children and adolescents","volume":"22","author":"Licari","year":"2020","journal-title":"Pediatr Drugs"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3390\/jcm15041373","article-title":"Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated T2 comorbidities: One-year real life round","volume":"15","author":"Nettis","year":"2026","journal-title":"J Clin Med"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3390\/biologics5010003","article-title":"Efficacy and safety of dupilumab across different Th2-type-mediated diseases: A real-life preliminary experience","volume":"5","author":"Romano","year":"2025","journal-title":"Biologics"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/JAA.S588165","article-title":"Eosinophilic organ complications associated with dupilumab therapy \u2013 narrative review and current evidence","volume":"19","author":"Suter","year":"2026","journal-title":"J Asthma Allergy"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003300","article-title":"Eosinophilic granulomatosis polyangiitis (EGPA) complicated with periaortitis, precipitating role of dupilumab? A case report a review of the literature","volume":"9","author":"Kai","year":"2023","journal-title":"RMD Open"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacig.2022.03.006","article-title":"Eosinophilic granulomatosis with polyangiitis after treatment with dupilumab","volume":"1","author":"Yamazaki","year":"2022","journal-title":"J Allergy Clin Immunology: Global"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-224756","article-title":"Dupilumab for relapsing or refractory sinonasal and\/or asthma manifestations in eosinophilic granulomatosis with polyangiitis: a European retrospective study","volume":"82","author":"Molina","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.alit.2021.11.003","article-title":"Successful concomitant therapy with mepolizumab and dupilumab for atypical eosinophilic granulomatosis with polyangiitis","volume":"71","author":"Anai","year":"2022","journal-title":"Allergology Int"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.33160\/yam.2024.05.005","article-title":"Combination biologic therapy with mepolizumab and dupilumab for severe eosinophilic granulomatosis with polyangiitis and chronic rhinosinusitis with nasal polyp","volume":"67","author":"Nakamura","year":"2024","journal-title":"Yonago Acta Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1964154\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:30:48Z","timestamp":1791192648000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1964154\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":59,"alternative-id":["10.3389\/fimmu.2026.1964154"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1964154","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,5]]},"article-number":"1964154"}}